FDA Requests Public Comment on New Guidelines for Antibiotic Resistance Monitoring

Summary

The US Food and Drug Administration (FDA) is seeking public input on its new guidelines for monitoring antibiotic resistance, as part of its National Antimicrobial Resistance Monitoring System (NARMS). The meeting aims to gather feedback from stakeholders on the proposed system, which will help inform the development of effective strategies to combat antibiotic resistance.